Skip to main content
. 2022 Feb 3;8:775194. doi: 10.3389/fsurg.2021.775194

Table 1.

Multi-variate Cox-regression analysis of CD44 expression with Age and Gender.

Dataset Group HR 95%CI p
TCGA All 1.5361 1.3669–1.726 5.68e-13 ***
WHO II 1.515 1.0482–2.189 0.0271 *
WHO III 1.3258 1.0868–1.617 0.00543 **
WHO IV 1.1447 0.9519–1.377 0.151
IDH mutant 1.2393 0.9928–1.547 0.057922
IDH wildtype 1.2441 1.0719–1.444 0.00406 **
1p19q codeletion 1.487 0.9152–2.416 0.109
1p19q Non-codeletion 1.3618 1.1942–1.553 4.03e-06 ***
CGGA All 1.2832 1.2107–1.360 0 ***
WHO II 1.191 1.0026–1.415 0.0467 *
WHO III 1.2822 1.1580–1.420 1.73e-06 ***
WHO IV 1.1233 1.0368–1.217 0.00448 **
IDH mutant 1.3049 1.1815–1.441 1.52e-07 ***
IDH wildtype 1.1274 1.0453–1.216 0.00188 **
1p19q codeletion 1.26 0.9945–1.596 0.0556
1p19q Non-codeletion 1.2018 1.1230–1.286 1.07e-07 ***
MGMT methylation 1.236 1.1297–1.352 3.78e-06 ***
MGMT Un-methylation 1.374 1.2460–1.514 1.79e-10 ***
Primary tumor 1.329 1.2164–1.451 2.69e-10 ***
Recurrent tumor 1.1573 1.0720–1.249 0.000184 ***

HR, hazard ratio; CI, confidence interval;

***

p < 0.001,

**

p < 0.01,

*

p < 0.05.